Coronavirus: Vaccination
The question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the recommendations of his Department's publication entitled JCVI statement on COVID-19 vaccination in 2025 and spring 2026, updated on 14 November 2024, on the clinically vulnerable population (a) nationally and (b) in Gosport.
Answered by Ashley Dalton
The independent Joint Committee on Vaccination and Immunisation (JCVI) advises the Department on the approach to vaccination and immunisation programmes. The aim of the COVID-19 vaccination programme is to prevent serious disease, leading to hospitalisation and/or mortality, arising from COVID-19.
For spring 2025, as in spring 2024, the JCVI advises that a COVID-19 vaccine should be offered to: adults aged 75 years old and over; residents in a care home for older adults; and the immunosuppressed aged six months old and over.
As in previous COVID-19 spring campaigns, the only clinical risk group included in the campaign are those aged six months or over with immunosuppression. The JCVI has advised that the available national data continues to demonstrate that older people and those who are immunosuppressed are at greatest risk of hospitalisation and death from COVID-19. The data available to the JCVI is national data, and they therefore made no assessment specific to Gosport.
The Government accepted the independent JCVI advice for spring 2025 on 12 December 2024. The Government is considering the advice on autumn 2025 and spring 2026 carefully, and will respond in due course.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →